News

A batch of 18 S&P 500 companies beat earnings-per-share expectations while maintaining year-on-year growth momentum, signalling resilient corporate profitability despite economic headwinds. This is moderately positive for equity markets as it suggests companies are managing costs and pricing power effectively. Australian investors exposed to US equities via index funds or direct holdings should note this supports the case for continued US market strength, though broader market reaction depends on forward guidance and whether these results are representative of the full earnings season.

Nvidia's strong revenue guidance has sparked investor speculation about whether SpaceX's exclusive GPU commitment is a primary driver, alongside broader AI demand from hyperscalers. While SpaceX's chip spending is material, the analysis highlights that Nvidia's growth is underpinned by multiple high-demand sectors—cloud providers, AI companies, and consumer gaming—rather than a single customer. For Australian investors, this reinforces Nvidia's dominance in the GPU supply chain and the structural tailwinds from AI adoption, though concentration risk around major customers remains a consideration. Watch for quarterly results disclosures on customer concentration and whether other aerospace/defence firms follow SpaceX's lead.

Iris Energy's massive $25–$30 billion AI infrastructure capex program has triggered investor concern about execution risk and capital intensity, despite strong contracted revenue metrics ($4B cloud ARR for 2026, >$20M per megawatt annually). The capex scale is significant relative to the company's current market cap, raising questions about dilution, financing costs, and ROI timing—particularly in a higher-rate environment where capital is expensive. Australian investors should monitor whether IREN can maintain pricing power and secure long-term contracts to justify the buildout, as weakness here could pressure the stock and signal broader uncertainty in the AI infrastructure race.

PayPal's stock is under pressure after potential acquirers reportedly withdrew takeover interest, removing a bullish catalyst that had supported the share price. The company now faces pressure to demonstrate standalone turnaround progress through operational improvements and cost management—investors will scrutinise upcoming earnings and management guidance. While PayPal's payment processing scale remains valuable, the failed M&A process highlights investor concerns about growth and profitability that the business must address independently.

Marvell Technology's share price declined as investors reacted negatively to details of its Google partnership, with analyst expectations apparently not materialising as hoped. This highlights how major tech partnerships can disappoint markets if commercial terms or revenue potential don't meet the hype—a common risk in semiconductor deals. Australian tech investors holding US semiconductor exposure should monitor whether this signals broader weakness in chip company valuations or if it's company-specific.

Civmec reported improved FY26 earnings with margin expansion and a $1.4b order book that signals visibility into FY27 growth. The strong order backlog is the key driver here—it suggests the company has secured work pipeline ahead, reducing revenue uncertainty and supporting investor confidence in near-term earnings delivery. For ASX investors, this is a positive earnings update for a mid-cap infrastructure play, though broader market impact depends on the company's guidance and whether margins can sustain as projects progress.

The ASX rallied on Friday as tech stocks, particularly those benefiting from Nvidia's momentum, drove gains across the market. Nvidia's strength—likely tied to AI demand and earnings performance—continues to lift sentiment in the broader tech sector, with Australian tech-exposed stocks riding the wave. Watch earnings season developments and Nvidia's next earnings call for cues on whether this momentum is sustainable or if valuations have run ahead of fundamentals.

Affirm Holdings, the US buy-now-pay-later (BNPL) fintech company, has moved higher on positive Q4 earnings results and forward guidance, alongside a management reshuffle with the appointment of a new co-president. For Australian investors, Affirm is a key fintech proxy and bellwether for the BNPL sector globally—a space that includes local ASX-listed player Zip Co ($Z.AX). A strong earnings beat and upbeat guidance suggest improving unit economics and consumer demand for BNPL services, which could benefit sentiment toward the broader sector, including Australian counterparts facing profitability questions.

Workday reported Q2 earnings that disappointed the market enough to trigger a share price decline, though the company simultaneously announced a $4 billion buyback authorization—a signal of confidence in long-term value. For Australian investors with US tech exposure, this reflects the sector's current tension between strong valuations and execution pressures. Watch forward guidance and margin trends to assess whether the stock decline represents a genuine slowdown or a buying opportunity for long-term holders.

Iridium Communications reported a widening Q4 loss driven by a substantial $450.4M impairment charge, though the company showed a bright spot with AI Cloud revenue doubling. The impairment suggests the company is writing down the value of assets—likely related to prior acquisitions or infrastructure investments—which signals management reassessment of long-term value. For Australian investors, this reflects broader tech sector challenges; however, the strong AI Cloud growth indicates recovery potential if the company can stabilize its balance sheet and grow that segment faster. Watch for guidance on whether this impairment is a one-off restructuring or signals deeper operational issues.

Nvidia posted strong earnings, but AI and chip stocks delivered mixed reactions—a common pattern when exceptional results are already priced in. For Australian investors, this matters because tech exposure in the ASX200 (via $XIT or direct holdings) is sensitive to US semiconductor sentiment; mixed breadth suggests selective strength rather than broad enthusiasm. Watch whether other chip makers' upcoming earnings can match Nvidia's bar, or if the market is recalibrating growth expectations.

Salesforce shares gained in premarket trading after earnings, with major analysts Citigroup and Jefferies raising price targets—a sign of confidence in the company's performance and forward guidance. The mention of its Anthropic relationship (Claude AI integration) suggests investors are pricing in growth from AI-powered features, a key theme for enterprise software. For Australian investors, Salesforce is a significant holding in many tech-focused portfolios and ASX tech stocks often track US software earnings sentiment; watch whether other local software/SaaS names follow on positive AI momentum.

Nvidia delivered strong earnings results, prompting major investment banks Goldman Sachs and Citigroup to raise price targets—a bullish signal from Wall Street. This matters because Nvidia is a bellwether for the AI and semiconductor sectors globally; strength here typically flows through to tech-heavy indices and AI-related stocks. For Australian investors, this supports the ASX 200's tech and resources exposure, though direct Nvidia shareholding in local portfolios is typically through ETFs or international holdings. Watch for whether this momentum sustains and whether other semiconductor peers follow suit.

Nvidia delivered an earnings beat, driving an 8% share price jump that lifted the broader technology sector and supported risk appetite across markets including cryptocurrency. For Australian investors, this matters because Nvidia is a mega-cap holding in most global tech indices and ETFs tracking the Nasdaq, so the move influences local portfolio returns—particularly through ASX-listed tech stocks and US-exposed managed funds. Watch whether this earnings strength signals sustained AI demand or if it's pricing in already-known growth, as guidance will be key to whether the momentum sticks.

Nvidia's doubling of quarterly revenue to ~$100bn has reignited AI enthusiasm across Asian tech stocks, providing relief after months of valuation concerns. This is significant for Australian investors because ASX semiconductor and tech holdings (particularly through the ASX200 and tech indices) track US AI momentum closely, while it also supports the outlook for regional tech supply chains. Watch for follow-through in other semiconductor earnings and any commentary on AI capex cycles—weakness here could quickly reverse the bullish sentiment, especially if demand growth disappoints versus the elevated expectations now priced in.

Deutsche Bank downgraded Novo Nordisk to sell following a 70% decline from its peak, marking a significant shift in Wall Street sentiment on the GLP-1 drug maker. The downgrade reflects concerns about the company's valuation and growth prospects as competition intensifies in the weight-loss and diabetes treatment markets. Australian investors with exposure to Novo Nordisk or healthcare ETFs should reassess their positions, particularly given the stock's extended pullback and the increased competitive pressure from rivals like Eli Lilly and Amgen in this space.

Nvidia's forward guidance is providing support to tech stocks across Asia, counterbalancing renewed concerns about sticky U.S. inflation that could influence Federal Reserve policy. This mixed sentiment reflects the tension between strong AI-driven demand (which favours large-cap tech) and macroeconomic headwinds from persistent price pressures. Australian investors should monitor whether Nvidia's strength flows through to local tech holdings and ASX-listed semiconductor exposure, while keeping tabs on U.S. inflation data as it shapes rate expectations.

Ramsay Health Care has reported a significant profit improvement in FY26, driven by stronger performance from its Australian hospital operations—a key driver of the company's overall recovery. This suggests improving operational efficiency and potentially better pricing dynamics in the private healthcare sector, which matters for investors in healthcare stocks and the broader healthcare sector ETFs. Watch for commentary on patient volumes, cost pressures, and whether this momentum can be sustained given ongoing wage inflation and competitive pressures in Australian private hospitals.

Qantas reported weaker earnings, weighing on market sentiment at a time when rising inflation expectations are pushing investors to bet on further RBA rate hikes. Higher interest rates hurt consumer spending (bad for discretionary stocks like airlines) and increase borrowing costs for corporates, which typically dampens equity valuations. Australian investors should watch Qantas's cost pressures and whether other earnings reports confirm a broader slowdown, as persistent inflation could force the RBA to stay restrictive longer than markets currently expect.

Chemist Warehouse and Sigma's merged entity has posted solid growth in its first full year post-integration, suggesting the combination is delivering operational and commercial synergies. This matters for investors holding either stock, as successful M&A integration de-risks the strategy and validates management's merger thesis. Watch for commentary on cost savings realisation, pharmacy network expansion, and competitive positioning against competitors like Endeavour Group and independent pharmacies.